Heather Moore, CPP, PharmD, highlights key contributions from pharmacists in breast cancer treatment and identifies current unmet needs in the treatment landscape.
Breast Cancer Insights: Updates from the 2023 ASCO Annual Meeting
Dr Moore provides a detailed summary of the scope and findings from the TROPiCS-02 study.
A description of the SONIA study is provided by Heather Moore, CPP, PharmD.
Dr Moore examines findings from the NATALEE trial.
In her final discussion, Dr Moore analyzes key differences between the NATALEE and moncarchE trials.
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
4
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
5
